Kalaris shares additional Phase 1a data for AMD treatment TH103
Kalaris shares additional Phase 1a data for AMD treatment TH103
Kalaris shares additional Phase 1a data for AMD treatment TH103
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.